TE_151
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | FAM |
|---|---|
| TE superfamily | Alu |
| TE class | SINE |
| Gene | FBXO42, - |
| Class | Chimeric, Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 16.42 |
| Counts of samples | TCGA_tumor:101; TCGA_normal:2; GTEx:4 |
| TSS | chr1(-):16279372 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_151.1 | - | Intergenic | Non-coding | Non-coding | chr1(-):16278076,16278096,16279075,16279373 |
| teRNA_151.2 | FBXO42 | Chimeric | Non-coding | Non-coding | chr1(-):16251765,16251785,16252288,16252404,16253096,16253152,16253635,16253731,16255711,16255821,16256606,16278096,16279075,16279373 |
| teRNA_151.3 | FBXO42 | Chimeric | Non-coding | Non-coding | chr1(-):16251765,16251785,16252288,16252404,16253096,16253152,16253635,16253731,16255711,16255821,16256606,16256759,16261001,16278096,16279075,16279373 |
| teRNA_151.4 | - | Intergenic | Non-coding | Non-coding | chr1(-):16263483,16263503,16264056,16278096,16279075,16279373 |
| teRNA_151.5 | - | Intergenic | Non-coding | Non-coding | chr1(-):16260270,16260290,16272265,16278096,16279075,16279373 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
